nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA9—gall bladder—pancreatic cancer	0.00811	0.195	CbGeAlD
Brinzolamide—CA9—islet of Langerhans—pancreatic cancer	0.00531	0.128	CbGeAlD
Brinzolamide—CA7—digestive system—pancreatic cancer	0.00363	0.0874	CbGeAlD
Brinzolamide—CA9—digestive system—pancreatic cancer	0.00319	0.0768	CbGeAlD
Brinzolamide—CA2—gall bladder—pancreatic cancer	0.00308	0.0741	CbGeAlD
Brinzolamide—CA5B—pancreas—pancreatic cancer	0.00248	0.0597	CbGeAlD
Brinzolamide—CA4—islet of Langerhans—pancreatic cancer	0.00243	0.0586	CbGeAlD
Brinzolamide—CA12—digestive system—pancreatic cancer	0.00236	0.0568	CbGeAlD
Brinzolamide—CA1—pancreas—pancreatic cancer	0.00219	0.0527	CbGeAlD
Brinzolamide—CA2—islet of Langerhans—pancreatic cancer	0.00202	0.0486	CbGeAlD
Brinzolamide—CA1—digestive system—pancreatic cancer	0.00187	0.045	CbGeAlD
Brinzolamide—CA4—digestive system—pancreatic cancer	0.00146	0.0352	CbGeAlD
Brinzolamide—CA2—pancreas—pancreatic cancer	0.00142	0.0341	CbGeAlD
Brinzolamide—CA2—digestive system—pancreatic cancer	0.00121	0.0292	CbGeAlD
Brinzolamide—Breast disorder—Epirubicin—pancreatic cancer	0.00115	0.0012	CcSEcCtD
Brinzolamide—Pain—Irinotecan—pancreatic cancer	0.00114	0.00119	CcSEcCtD
Brinzolamide—Dyspnoea—Fluorouracil—pancreatic cancer	0.00114	0.00119	CcSEcCtD
Brinzolamide—Mental disorder—Docetaxel—pancreatic cancer	0.00114	0.00119	CcSEcCtD
Brinzolamide—Somnolence—Fluorouracil—pancreatic cancer	0.00114	0.00119	CcSEcCtD
Brinzolamide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00113	0.00118	CcSEcCtD
Brinzolamide—Malnutrition—Docetaxel—pancreatic cancer	0.00113	0.00118	CcSEcCtD
Brinzolamide—Erythema—Docetaxel—pancreatic cancer	0.00113	0.00118	CcSEcCtD
Brinzolamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00113	0.00118	CcSEcCtD
Brinzolamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00113	0.00118	CcSEcCtD
Brinzolamide—Nausea—Tamoxifen—pancreatic cancer	0.00113	0.00117	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00112	0.00117	CcSEcCtD
Brinzolamide—Fatigue—Gemcitabine—pancreatic cancer	0.00112	0.00117	CcSEcCtD
Brinzolamide—Pain—Gemcitabine—pancreatic cancer	0.00111	0.00116	CcSEcCtD
Brinzolamide—Nausea—Erlotinib—pancreatic cancer	0.00111	0.00116	CcSEcCtD
Brinzolamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.00111	0.00116	CcSEcCtD
Brinzolamide—Diarrhoea—Sunitinib—pancreatic cancer	0.00111	0.00116	CcSEcCtD
Brinzolamide—Dysgeusia—Docetaxel—pancreatic cancer	0.00111	0.00116	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00111	0.00115	CcSEcCtD
Brinzolamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.0011	0.00115	CcSEcCtD
Brinzolamide—Asthma—Epirubicin—pancreatic cancer	0.0011	0.00114	CcSEcCtD
Brinzolamide—Back pain—Docetaxel—pancreatic cancer	0.0011	0.00114	CcSEcCtD
Brinzolamide—Pain—Fluorouracil—pancreatic cancer	0.00109	0.00114	CcSEcCtD
Brinzolamide—Muscle spasms—Docetaxel—pancreatic cancer	0.00109	0.00114	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00108	0.00113	CcSEcCtD
Brinzolamide—Dizziness—Sunitinib—pancreatic cancer	0.00107	0.00112	CcSEcCtD
Brinzolamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00107	0.00112	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00107	0.00112	CcSEcCtD
Brinzolamide—Angina pectoris—Epirubicin—pancreatic cancer	0.00107	0.00111	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—pancreatic cancer	0.00106	0.00111	CcSEcCtD
Brinzolamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00106	0.0011	CcSEcCtD
Brinzolamide—Bronchitis—Epirubicin—pancreatic cancer	0.00105	0.0011	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00105	0.00109	CcSEcCtD
Brinzolamide—Vomiting—Sunitinib—pancreatic cancer	0.00103	0.00108	CcSEcCtD
Brinzolamide—Rash—Sunitinib—pancreatic cancer	0.00102	0.00107	CcSEcCtD
Brinzolamide—Dermatitis—Sunitinib—pancreatic cancer	0.00102	0.00107	CcSEcCtD
Brinzolamide—Urticaria—Fluorouracil—pancreatic cancer	0.00102	0.00106	CcSEcCtD
Brinzolamide—Headache—Sunitinib—pancreatic cancer	0.00102	0.00106	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—pancreatic cancer	0.00101	0.00106	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—pancreatic cancer	0.00101	0.00106	CcSEcCtD
Brinzolamide—Palpitations—Docetaxel—pancreatic cancer	0.001	0.00104	CcSEcCtD
Brinzolamide—Cough—Docetaxel—pancreatic cancer	0.000988	0.00103	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000988	0.00103	CcSEcCtD
Brinzolamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000985	0.00103	CcSEcCtD
Brinzolamide—Hypertension—Docetaxel—pancreatic cancer	0.000978	0.00102	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—pancreatic cancer	0.000977	0.00102	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—pancreatic cancer	0.000977	0.00102	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—pancreatic cancer	0.000975	0.00102	CcSEcCtD
Brinzolamide—Myalgia—Docetaxel—pancreatic cancer	0.000964	0.00101	CcSEcCtD
Brinzolamide—Chest pain—Docetaxel—pancreatic cancer	0.000964	0.00101	CcSEcCtD
Brinzolamide—Arthralgia—Docetaxel—pancreatic cancer	0.000964	0.00101	CcSEcCtD
Brinzolamide—Nausea—Sunitinib—pancreatic cancer	0.000964	0.00101	CcSEcCtD
Brinzolamide—Asthenia—Irinotecan—pancreatic cancer	0.000959	0.001	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000957	0.000999	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—pancreatic cancer	0.00095	0.000991	CcSEcCtD
Brinzolamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000943	0.000984	CcSEcCtD
Brinzolamide—Dry mouth—Docetaxel—pancreatic cancer	0.000943	0.000984	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000937	0.000978	CcSEcCtD
Brinzolamide—Asthenia—Gemcitabine—pancreatic cancer	0.000934	0.000975	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000924	0.000964	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—pancreatic cancer	0.000922	0.000962	CcSEcCtD
Brinzolamide—Pruritus—Gemcitabine—pancreatic cancer	0.000921	0.000961	CcSEcCtD
Brinzolamide—Infection—Docetaxel—pancreatic cancer	0.000918	0.000958	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—pancreatic cancer	0.000917	0.000957	CcSEcCtD
Brinzolamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000915	0.000954	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000906	0.000946	CcSEcCtD
Brinzolamide—Pruritus—Fluorouracil—pancreatic cancer	0.000906	0.000945	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—pancreatic cancer	0.000904	0.000943	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—pancreatic cancer	0.000904	0.000943	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—pancreatic cancer	0.000902	0.000941	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—pancreatic cancer	0.000898	0.000937	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—pancreatic cancer	0.000893	0.000932	CcSEcCtD
Brinzolamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000891	0.00093	CcSEcCtD
Brinzolamide—Dizziness—Irinotecan—pancreatic cancer	0.000884	0.000922	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—pancreatic cancer	0.00088	0.000918	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000879	0.000917	CcSEcCtD
Brinzolamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000876	0.000914	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000873	0.000911	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—pancreatic cancer	0.000871	0.000909	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000866	0.000904	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000864	0.000902	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—pancreatic cancer	0.000864	0.000901	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000862	0.0009	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—pancreatic cancer	0.00086	0.000897	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000855	0.000892	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—pancreatic cancer	0.000853	0.00089	CcSEcCtD
Brinzolamide—Vomiting—Irinotecan—pancreatic cancer	0.00085	0.000887	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—pancreatic cancer	0.000848	0.000885	CcSEcCtD
Brinzolamide—Dizziness—Fluorouracil—pancreatic cancer	0.000847	0.000883	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—pancreatic cancer	0.000845	0.000882	CcSEcCtD
Brinzolamide—Rash—Irinotecan—pancreatic cancer	0.000843	0.000879	CcSEcCtD
Brinzolamide—Dermatitis—Irinotecan—pancreatic cancer	0.000842	0.000879	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000842	0.000878	CcSEcCtD
Brinzolamide—Headache—Irinotecan—pancreatic cancer	0.000837	0.000874	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—pancreatic cancer	0.000836	0.000872	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—pancreatic cancer	0.00083	0.000866	CcSEcCtD
Brinzolamide—Vomiting—Gemcitabine—pancreatic cancer	0.000828	0.000864	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—pancreatic cancer	0.000826	0.000862	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—pancreatic cancer	0.000824	0.00086	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—pancreatic cancer	0.000822	0.000857	CcSEcCtD
Brinzolamide—Rash—Gemcitabine—pancreatic cancer	0.000821	0.000857	CcSEcCtD
Brinzolamide—Dermatitis—Gemcitabine—pancreatic cancer	0.00082	0.000856	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—pancreatic cancer	0.00082	0.000855	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—pancreatic cancer	0.000818	0.000853	CcSEcCtD
Brinzolamide—Headache—Gemcitabine—pancreatic cancer	0.000816	0.000851	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—pancreatic cancer	0.000814	0.00085	CcSEcCtD
Brinzolamide—Vomiting—Fluorouracil—pancreatic cancer	0.000814	0.000849	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—pancreatic cancer	0.000814	0.000849	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—pancreatic cancer	0.000813	0.000849	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000808	0.000843	CcSEcCtD
Brinzolamide—Rash—Fluorouracil—pancreatic cancer	0.000807	0.000842	CcSEcCtD
Brinzolamide—Dermatitis—Fluorouracil—pancreatic cancer	0.000807	0.000842	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000806	0.000841	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—pancreatic cancer	0.000803	0.000838	CcSEcCtD
Brinzolamide—Headache—Fluorouracil—pancreatic cancer	0.000802	0.000837	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000802	0.000836	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.0008	0.000834	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000798	0.000832	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000798	0.000832	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—pancreatic cancer	0.000797	0.000831	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—pancreatic cancer	0.000796	0.00083	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000796	0.00083	CcSEcCtD
Brinzolamide—Nausea—Irinotecan—pancreatic cancer	0.000794	0.000828	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—pancreatic cancer	0.000792	0.000827	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000791	0.000825	CcSEcCtD
Brinzolamide—Pain—Docetaxel—pancreatic cancer	0.00079	0.000825	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—pancreatic cancer	0.000784	0.000818	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—pancreatic cancer	0.000782	0.000816	CcSEcCtD
Brinzolamide—CYP3A4—digestive system—pancreatic cancer	0.000782	0.0188	CbGeAlD
Brinzolamide—Alopecia—Epirubicin—pancreatic cancer	0.000775	0.000809	CcSEcCtD
Brinzolamide—Nausea—Gemcitabine—pancreatic cancer	0.000773	0.000807	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—pancreatic cancer	0.000769	0.000802	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—pancreatic cancer	0.000764	0.000797	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—pancreatic cancer	0.000764	0.000797	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000762	0.000795	CcSEcCtD
Brinzolamide—Nausea—Fluorouracil—pancreatic cancer	0.000761	0.000793	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—pancreatic cancer	0.000759	0.000792	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—pancreatic cancer	0.000757	0.00079	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000753	0.000786	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—pancreatic cancer	0.000753	0.000785	CcSEcCtD
Brinzolamide—Tension—Epirubicin—pancreatic cancer	0.000749	0.000782	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—pancreatic cancer	0.000748	0.00078	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—pancreatic cancer	0.000742	0.000774	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—pancreatic cancer	0.000739	0.000771	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—pancreatic cancer	0.000737	0.000768	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—pancreatic cancer	0.000734	0.000766	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000733	0.000765	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000732	0.000763	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000725	0.000757	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—pancreatic cancer	0.00072	0.000751	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—pancreatic cancer	0.000717	0.000748	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—pancreatic cancer	0.000711	0.000742	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000709	0.000739	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—pancreatic cancer	0.000707	0.000737	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—pancreatic cancer	0.000707	0.000737	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—pancreatic cancer	0.000702	0.000732	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—pancreatic cancer	0.000696	0.000727	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—pancreatic cancer	0.000693	0.000724	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000692	0.000722	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—pancreatic cancer	0.000689	0.000719	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—pancreatic cancer	0.000686	0.000716	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—pancreatic cancer	0.000686	0.000716	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—pancreatic cancer	0.000684	0.000713	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000681	0.00071	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000679	0.000709	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—pancreatic cancer	0.000675	0.000704	CcSEcCtD
Brinzolamide—Cough—Epirubicin—pancreatic cancer	0.000666	0.000695	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—pancreatic cancer	0.000666	0.000695	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—pancreatic cancer	0.000663	0.000692	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—pancreatic cancer	0.000659	0.000688	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000656	0.000684	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—pancreatic cancer	0.000654	0.000682	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—pancreatic cancer	0.00065	0.000678	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—pancreatic cancer	0.00065	0.000678	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—pancreatic cancer	0.00065	0.000678	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—pancreatic cancer	0.000649	0.000678	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000646	0.000674	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—pancreatic cancer	0.000642	0.00067	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—pancreatic cancer	0.000637	0.000665	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—pancreatic cancer	0.000636	0.000663	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—pancreatic cancer	0.000635	0.000662	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000632	0.00066	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—pancreatic cancer	0.000624	0.000652	CcSEcCtD
Brinzolamide—Infection—Epirubicin—pancreatic cancer	0.000619	0.000646	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—pancreatic cancer	0.000617	0.000643	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000611	0.000638	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—pancreatic cancer	0.000611	0.000638	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—pancreatic cancer	0.00061	0.000637	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—pancreatic cancer	0.000608	0.000635	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—pancreatic cancer	0.000605	0.000632	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—pancreatic cancer	0.000602	0.000628	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—pancreatic cancer	0.000602	0.000628	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—pancreatic cancer	0.000602	0.000628	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000597	0.000623	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—pancreatic cancer	0.000594	0.00062	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—pancreatic cancer	0.000588	0.000614	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—pancreatic cancer	0.000588	0.000613	CcSEcCtD
Brinzolamide—Rash—Docetaxel—pancreatic cancer	0.000583	0.000608	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—pancreatic cancer	0.000582	0.000608	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—pancreatic cancer	0.000582	0.000607	CcSEcCtD
Brinzolamide—Headache—Docetaxel—pancreatic cancer	0.000579	0.000604	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—pancreatic cancer	0.000573	0.000598	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000568	0.000593	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000566	0.00059	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—pancreatic cancer	0.000564	0.000588	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—pancreatic cancer	0.000563	0.000587	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—pancreatic cancer	0.00056	0.000584	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—pancreatic cancer	0.00056	0.000584	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—pancreatic cancer	0.000556	0.00058	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—pancreatic cancer	0.000554	0.000578	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—pancreatic cancer	0.000549	0.000573	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000549	0.000572	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000542	0.000565	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—pancreatic cancer	0.000539	0.000562	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000538	0.000561	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—pancreatic cancer	0.000537	0.000561	CcSEcCtD
Brinzolamide—Pain—Epirubicin—pancreatic cancer	0.000533	0.000556	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000525	0.000548	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—pancreatic cancer	0.000522	0.000544	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000518	0.00054	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000514	0.000536	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000514	0.000536	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—pancreatic cancer	0.000513	0.000535	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000508	0.00053	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000501	0.000523	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000498	0.00052	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—pancreatic cancer	0.000497	0.000519	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—pancreatic cancer	0.000495	0.000517	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—pancreatic cancer	0.000493	0.000515	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000475	0.000496	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000459	0.000479	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—pancreatic cancer	0.000458	0.000478	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—pancreatic cancer	0.000447	0.000467	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—pancreatic cancer	0.000441	0.00046	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000426	0.000445	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000425	0.000443	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—pancreatic cancer	0.000414	0.000432	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—pancreatic cancer	0.000412	0.00043	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—pancreatic cancer	0.000408	0.000426	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—pancreatic cancer	0.000396	0.000413	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000395	0.000412	CcSEcCtD
Brinzolamide—Rash—Epirubicin—pancreatic cancer	0.000393	0.00041	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—pancreatic cancer	0.000393	0.00041	CcSEcCtD
Brinzolamide—Headache—Epirubicin—pancreatic cancer	0.00039	0.000407	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—pancreatic cancer	0.000381	0.000398	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—pancreatic cancer	0.00037	0.000386	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—pancreatic cancer	0.000367	0.000383	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—pancreatic cancer	0.000364	0.000379	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—pancreatic cancer	0.000363	0.000379	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—pancreatic cancer	0.000361	0.000377	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—pancreatic cancer	0.000343	0.000357	CcSEcCtD
